Epothilones and their analogues - a new class of promising microtubule inhibitors

Bibliography

• GERTH K, BEDORF N, HOFLE G, IRSCHIK H, REICHENBACH H: Antibiotics from gliding bacteria. 74. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum(Myxobacteria): production, physico-chemical and biological properties. Antibiotics(1996), 49: 560–564.
   Google Scholar
• BOLLAG DM, MCQUENEY PA, ZHU J et al.:Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res.(1995) 55:2325–2333.
   PubMed Web of Science ®Google Scholar
• •This paper is the first to demonstrate that the cytotoxicity of epothilones is based on a paclitaxel-like mechanism of action.
   Google Scholar
• KOWALSKI RJ, GIANNAKAKOU P, HAMEL E: Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel. j Biol. Chem.(1997) 272:2534–2541.
   PubMed Web of Science ®Google Scholar
• TER HAAR E, KOWALSKI RJ, HAMEL E et al.:Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry(1996) 35:243–50),
   PubMed Web of Science ®Google Scholar
• LONG BH, CARBONI JM, WASSERMAN AJ et al.:Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxo18). Cancer Res.(1998) 58:1111–1115.
   PubMed Web of Science ®Google Scholar
• MOOBERRY SL, TIEN G, HERNANDEZ AH, PLUBRURKAN A, DAVIDSON BS: Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res.(1999) 59:653–660.
   PubMed Web of Science ®Google Scholar
• ALTMANN K-H, WARTMANN M, O'REILLY T: Epothilones and related structures - a new class of microtubule inhibitors with potent in vivoantitumor activity. Biochim. Biophys. Acta(2000) 1470: M79–M91.
   Google Scholar
• •A thoroughreviewofthebiologicalpropertiesofepothilonesA andB.
   Google Scholar
• CHOU T-C, ZHANG X-G, BALOG A et al.:Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivoprofile relative to epothilone B. Proc. Nati Acad. Sri. USA(1998) 95:9642–9647.
   PubMedGoogle Scholar
• •First demonstrationofthepotentinvivoantitumouractivityofepothiloneD.
   Google Scholar
• HOFLE G, BEDORF N, STEINMETZH, SCHOMBERG D, GERTH K, REICHENBACH H: Antibiotics from gliding bacteria. 77. Epothilone A and B - novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure and conformation in solution. Angew. Chem. Int. Ed. Engl.(1996) 35:1567–1569.
   Google Scholar
• NICOLAOU KC, ROSCHANGAR F, VOURLOUMIS D: Chemical biology of epothilones. Angew. Chem. Int. Ed. Engl.(1998) 37:2014–2045.
   PubMed Web of Science ®Google Scholar
• HARRIS, CR; DANISHEFSKY, SJ: Complex target-oriented synthesis in the drug discovery process: a case history in the dEpoB series. ..J. Org. Chem.(1999) 64:8434–8456.
   Web of Science ®Google Scholar
• MENG D, SU D-S, BALOG A et al.:Remote effects in macrolide formation through ring-forming olefin metathesis: an application to the synthesis of fully active epothilone congeners. j Am. Chem. Soc.(1997) 119:2733–2734.
   Google Scholar
• DANISHEFSKY SJ, ZHENG Y-H, CHOU TC, HE L, HORWITZ SB: Total synthesis of 0-epothilone B: an extension of the Suzuki coupling method and insights into structure-activity relationships of the epothilones. Angew. Chem. Int. Ed. Engl.(1997) 36:757–759.
   Google Scholar
• SU D-S, BALOG A, MENG D et al.:Structure-activity relationships of the epothilones and the first in vivocomparison with paclitaxel. Angew. Chem. Bar Ed. Engl.(1997) 36:2093–2096.
   Google Scholar
• HOFLE G, GLASER N, KIFFE M, HECHT HJ, SASSE F, REICHENBACH H: N-oxidation of epothilone A-C and 0-acyl rearrangement to C-19- and C21-substituted epothilones. Angew. Chem Int. Ed. Engl.(1999) 38:1971–1974.
   PubMed Web of Science ®Google Scholar
• BORZILLERI RM, ZHENG X, SCHMIDT RJ et al.:A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products. j Am. Chem. Soc.(2000) 122:8890–8897.
   Web of Science ®Google Scholar
• ••The paper describes an ingenious methodfortheconversionofepothilonesA andB into the corresponding lactam analogs. In addition, it contains the first biological dataforBMS247550.
   Google Scholar
• NICOLAOU KC, VOURLOUMIS D, LI T et al.:Designed epothilones: combinatorial synthesis, tubulin assembly properties and cytotoxic actions against taxol-resistant tumor cells. Angew. Chem. Int. Ed Engl.(1997) 36: 2097–2102.
   Google Scholar
• SEFKOW M, KIFFE M, HOFLE G: Derivatization of the C12-C13 functional group of epothilones A, B and C. Bioorg. Med. Chem. Lett.(1998) 8:3031–3036.
   PubMedGoogle Scholar
• SEFKOW M, KIFFE M, SCHUMMER D, HOFLE G: Oxidative and reductive transformations of epothilone A. Bioorg. Med. Chem. Lett.(1998) 8:3025–3030.
   PubMedGoogle Scholar
• JOHNSON J, KIM S-H, BIFANO M et al.:Synthesis, structure proof and biological activity of epothilone cyclopropanes. Org. Lett.(2000) 2:1537–1540.
   PubMedGoogle Scholar
• •An important SAR paper,whichclarifiedthe significance of the epoxide oxygen for biological activity.
   Google Scholar
• NICOLAOU KC, NAMOTO K, LI J et al.: Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilones. Chem. Biochem(2001) 2:69–75.
   Google Scholar
• NICOLAOU KC, FINLAY MRV, NINKOVIC S et al.:Synthesis and biological properties of C12,13-cyclopropyl-epothilone A and related epothilones. Chem. Biol.(1998) 5:365–372.
   PubMedGoogle Scholar
• SEFKOW M, HOFLE G: Substitutions at the thiazole moiety of epothilone. Heterocycles(1998) 48:2485–2488.
   Google Scholar
• NICOLAOU KC, HEY, ROSCHANGAR F, KING NP, VOURLOUMIS D, LI T: Total synthesis of epothilone E and analogs with modified side chains through the Stille coupling reaction. Angew. Chem. Bar Ed.(1998) 37:84–87.
   Google Scholar
• NICOLAOU KC, SCARPELLI R, BOLLBUCK B et al.:Chemical synthesis and biological properties of pyridine epothilones. Chem. Biol.(2000), 7:593–599.
   PubMed Web of Science ®Google Scholar
• •Important SAR paper,whichdemonstratesthat methylation of the pyridine ring in pyridine-basedanaloguesofepothiloneB can enhance biological activity.
   Google Scholar
• MOLNAR I, SCHUPP T, ONO M et al.:The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosumSo ce90. Chem. Biol.(2000) 7:97–109.
   PubMed Web of Science ®Google Scholar
• JULIEN B, SHAH S, ZIERMANN R etal.:Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene(2000) 249:153–160.
   Google Scholar
• TANG L, SHAH S, CHUNG L et al.:Cloning and heterologous expression of the epothilone gene cluster. Science(2000) 287:640–642.
   PubMed Web of Science ®Google Scholar
• NICOLAOU KC, NINKOVIC S, FINLAY MRV, KING NP, WERSCHKUN B, BIGOT A: Total synthesis of 26-hydroxyepothilone B and related analogs. JCS Chem. Commun.(1997):2343–2344.
   Google Scholar
• CHOU T-C, ZHANG X-G, HARRIS CR et al.:Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. Proc. Natl. Acad. Li. USA(1998) 95:15798–15802.
   PubMedGoogle Scholar
• •An extension of the in vivo dataset availablefor epothilone D with particular emphasis on the comparison with paclitaxel upon iv. administration.
   Google Scholar
• NICOLAOU KC, SARABIA F, NINKOVIC S, FINLAY MRV, BODDY CNC: Probing the ring size of epothilones: total synthesis of [141-, [151-, [171- and [181Epothilones A. Angew. Chem. Int. Ed.(1998) 37:81–84.
   Web of Science ®Google Scholar
• ALTMANN K-H, BOLD G, CARAVATTI G et al.:Epothilones and their analogs - potential new weapons in the fight against cancer. Chimia(2000) 54:612–621.
   Google Scholar
• ALTMANN K-H, BOLD G, CARAVATTI G, FLORSHEIMER A, GUAGNANO V, WARTMANN M: Synthesis and biological evaluation of highly potent analogues of epothilones B and D. Bioorg. Med. Chem. Lett.(2000) 10:2765–2768.
   PubMedGoogle Scholar
• •The paper describes a new class of epothilone D analogs with significantly higher antiproliferative activity than epothilone D itself.
   Google Scholar
• NOGALES E, WOLF SG, DOWNING KH: Structure of the c13 tubulin dimer by electron crystallography. Nature(1998) 391:199–203.
   PubMed Web of Science ®Google Scholar
• •An electron-crystallographic structure at 3.7 A resolution is reported for 2-dimensional tubulin-polymer sheets with bound docetaxel.
   Google Scholar
• OJIMA I, CHAKRAVATY S, INOUE T et al.:A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc. Natl. Acad. Li. USA(1999) 96:4256–4261.
   PubMed Web of Science ®Google Scholar
• WANG M, XIA X, KIM Y etal.:A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone. Org. Lett.(1999) 1:43–46.
   Google Scholar
• GIANNAKAKOU E GUSSIO R, NOGALES E et al.:A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl. Acad. Sci. USA(2000) 97:2904–2909.
   Google Scholar
• ROWINSKY EK: The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Ann. Rev. Med.(1997) 48:353-374. Patents
   Google Scholar